Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-11-9
|
pubmed:abstractText |
On the background of the emerging concept of G protein-coupled sphingolipid receptors, Ca2+ mobilization by sphingosylphosphorylcholine (SPPC) in intact cells and SPPC-induced Ca2+ release in permeabilized cells, both occurring at similar, micromolar concentrations, were characterized and compared. In intact human embryonic kidney (HEK-293) cells, SPPC rapidly increased [Ca2+]i by mobilization of Ca2+ from thapsigargin-sensitive stores. In saponin-permeabilized HEK-293 cells, SPPC released stored Ca2+, in a manner similar to but independent of inositol 1,4,5-trisphosphate. Only the action of SPPC on intact cells, but not that in permeabilized cells, was, at least in part, sensitive to pertussis toxin. In addition and most important, Ca2+ release by SPPC in permeabilized cells was not stereoselective, whereas in intact cells only the naturally occurring D-erythro-SPPC, but not L-threo-SPPC, increased [Ca2+]i. Stereoselectivity of SPPC-induced [Ca2+]i increase was also demonstrated in bovine aortic endothelial cells. In conclusion, Ca2+ mobilization by SPPC in intact cells is independent of the previously described SPPC-gated Ca2+ channel on endoplasmic reticulum but probably mediated by a membrane sphingolipid receptor. Thus, SPPC can regulate Ca2+ homeostasis by acting apparently at two cellular targets, which exhibit clearly distinct recognition patterns.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphorylcholine,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Saponins,
http://linkedlifedata.com/resource/pubmed/chemical/Sphingolipids,
http://linkedlifedata.com/resource/pubmed/chemical/Sphingosine,
http://linkedlifedata.com/resource/pubmed/chemical/sphingosine phosphorylcholine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0014-2999
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
31
|
pubmed:volume |
354
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9726638-Animals,
pubmed-meshheading:9726638-Binding Sites,
pubmed-meshheading:9726638-Calcium,
pubmed-meshheading:9726638-Cattle,
pubmed-meshheading:9726638-Cell Membrane,
pubmed-meshheading:9726638-Cell Membrane Permeability,
pubmed-meshheading:9726638-Cells, Cultured,
pubmed-meshheading:9726638-Endothelium, Vascular,
pubmed-meshheading:9726638-Humans,
pubmed-meshheading:9726638-Kidney,
pubmed-meshheading:9726638-Phosphorylcholine,
pubmed-meshheading:9726638-Receptors, Cell Surface,
pubmed-meshheading:9726638-Saponins,
pubmed-meshheading:9726638-Sphingolipids,
pubmed-meshheading:9726638-Sphingosine,
pubmed-meshheading:9726638-Stereoisomerism
|
pubmed:year |
1998
|
pubmed:articleTitle |
Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine.
|
pubmed:affiliation |
Institut für Pharmakologie, Universitätsklinikum Essen, Germany. meyer-heringdorf@uni-essen.de
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|